Breast cancer patients have new treatment to try as Roche's Kadcyla gets EU approval
In draft guidance NICE denies early use of Velcade and asks for more data from Janssen
Once-daily COPD treatment, Striverdi Respimat, gets first European approvals
Final guidance from NICE recommends the use of Jetrea in patients suffering from sight-threatening condition
NICE draft guidance recommends prostate cancer treatment for adults
In a draft guidance NICE is recommending the use of rituximab as an optional treatment of rare autoimmune disease
Paediatric patients to benefit from EC's license extension for antiepileptic agent
New test to guide breast cancer treatment decisions recommended by NICE
Guidance from NICE is not recommending crizotinib for previously treated lung cancer as it's not good value for money
Page 1 of 40
Allergic to school?Allergy to school is just an excuse children would like to use on occasion; however, allergy to items found in classrooms is the real deal.
The more eye-catching news we have posted this week:
Copyright 2013: Primary Care UK - Part of Atalink Ltd.
Please Note: The information on this site is intended for healthcare professionals only.